How many patients are switching to biosimilars?

That is a key question if long-run drug prices are going to come down for biologic products. We can decompose this question into 3 sub-questions: What share patients initiating therapy start on a biosimilar?What share of patients already using a biologic products switch to a biosimilar?Do patient of physician factors drive biosimilar prescribing patterns? A…

Read More

The Rapidly Evolving Field of Street Medicine

The rapidly evolving field of street medicine — the practice of providing health care to homeless people living outside — is getting a jolt in California with a new player: a medical group devoted exclusively to homeless people. And it’s actually making money. Sachin Jain, who worked on federal Medicaid policy during his tenure in…

Read More